CEACAM5 and non-small cell lung carcinoma: NSCLC CTC ScoreD demonstrates high diagnostic performance for early‐stage NSCLC, achieving an area under the receiver operating characteristic curve (AUC) of 0.93, significantly outperforming serum CEA (AUC = 0.70).